Clinical Trial Update: Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2 study that compares pegfilgrastim with filgrastim as adjuncts to chemotherapy in acute myeloid leukemia. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• NEULASTA (pegfilgrastim)
• Neupogen (Filgrastim)

Snippet

Sponsor: Amgen | Conditions: Myeloid Leukemia | Phase 2 | Status: COMPLETED